http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012139469-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e180aa7b674be890e3788c0d80615ba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d4dc8f7db08607c344fa0afbad4f8e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7343a2d9b29e818a63bf3a239a52718a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a10a0bb2b4d3e168f84f0a1247dc130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fac86648f51e53ac874f186804f2aa9
publicationDate 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012139469-A1
titleOfInvention Delivery system and preparation of low-interference rna drug
abstract A delivery system and preparation of siRNA, with nanoparticles enclosing siRNA as an active ingredient, wherein the nano-particles are formed by a polymer and a cationic lipid, the polymer is a di-block or tri-block copolymer of polyethylene glycol-polylactic acid or polyethylene glycol-poly(lactic acid-glycolic acid), the cationic lipid is N,N-dihydroxyethyl-N-methyl-N-2-(cholesteroloxy carbonylamino) ethylammonium bromide or (2,3-dioleyloxy propyl) trimethylammonium chloride. The nanoparticle and preparation can desirably deliver siRNA to a cell and effectively silence expression of a target gene. Moreover, after being modified by a ligand or antibody, the siRNA delivery system can desirably silence the target gene at both a cellular level and an animal level.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019128611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2795400-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492620-B2
priorityDate 2011-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312402-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226667078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16730297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226702305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238276705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227923404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327409137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70873223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238278612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226505598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9961686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6913074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226844647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128086918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70874055

Total number of triples: 45.